-
A randomized controlled trial of newly diagnosed type 2 diabetic patients not on insulin showed an increased depression score in those performing home glucose monitoring and no improvement in glycemic control.
-
A short-acting dihydropyridine calcium channel blocker with a rapid onset of action has been approved for intravenous use to reduce blood pressure.
-
The established causal relationship between endothelial dysfunction and erectile dysfunction (ED) provides mechanistic insight into an obesity-sexual health linkage.
-
The ECG shown was interpreted as showing sinus rhythm with blocked premature atrial contractions (PACs) as the reason for the slow rate.
-
Guidelines for prediabetes from The American College of Endocrinology; statins for the prevention of dementia? Possible help for women suffering from sexual side effects while on antidepressants; government incentives for electronic prescribing; FDA Actions.
-
-
Extending the current grace period for reinjection of the contraceptive shot depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer) from two to four weeks does not increase pregnancy risk and could increase contraceptive continuation, indicate findings from a newly published study.
-
If your clinic is using oral fluid samples for rapid HIV testing, be sure to monitor for false-positive results.
-
Regulatory review of a second human papillomavirus (HPV) vaccine has been delayed. GlaxoSmithKline has announced plans to submit additional data from its large-scale clinical trial for its vaccine candidate, Cervarix.
-
Add a new resource on menopause management to your clinical practice. The North American Menopause Society (NAMS) has just updated its guidelines on postmenopausal hormone therapy.
